BCPWM
NAMS icon

Bradley & Co Private Wealth Management’s NewAmsterdam Pharma NAMS Stock Holding History

Bradley & Co Private Wealth Management’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$14K Hold
729
– – 0.01% 107
2024
Q1 		$17.2K Buy
+729
New +$14.8K 0.01% 107

Other funds holding NAMS

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bradley & Co Private Wealth Management's NAMS Position: Q2 2024 in Review

Bradley & Co Private Wealth Management held its NewAmsterdam Pharma (NAMS) position steady in Q2 2024 at 729 shares worth $14K. The position accounts for 0.01% of the portfolio, ranked #107.

Bradley & Co Private Wealth Management first reported a position in NAMS in Q1 2024 and has held it in 2 quarters since. The position peaked at $17.2K in Q1 2024. 90 funds tracked by Wall St. Rank hold NAMS as of Q2 2024.

  • Bradley & Co Private Wealth Management held 729 shares of NewAmsterdam Pharma worth $14K as of Q2 2024.
  • Bradley & Co Private Wealth Management left its NewAmsterdam Pharma share count unchanged in Q2 2024.
  • NewAmsterdam Pharma made up 0.01% of Bradley & Co Private Wealth Management's portfolio in Q2 2024, its #107 holding.
  • Bradley & Co Private Wealth Management first reported a position in NewAmsterdam Pharma in Q1 2024 and has held it in 2 quarters since.
  • Bradley & Co Private Wealth Management's NewAmsterdam Pharma position peaked at $17.2K in Q1 2024.
  • 90 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2024.

Based on Bradley & Co Private Wealth Management's 13F filing for Q2 2024, filed 31 Jul 2024.